Atıf Formatları
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

U. Kefeli Et Al. , "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience," ONCOLOGY LETTERS , vol.6, pp.605-611, 2013

Kefeli, U. Et Al. 2013. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. ONCOLOGY LETTERS , vol.6 , 605-611.

Kefeli, U., BENEKLİ, M., Sevinc, A., Yildiz, R., Kaplan, M. A. , Ciltas, A., ... Balakan, O.(2013). Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. ONCOLOGY LETTERS , vol.6, 605-611.

Kefeli, Umut Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience," ONCOLOGY LETTERS , vol.6, 605-611, 2013

Kefeli, Umut Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience." ONCOLOGY LETTERS , vol.6, pp.605-611, 2013

Kefeli, U. Et Al. (2013) . "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience." ONCOLOGY LETTERS , vol.6, pp.605-611.

@article{article, author={Umut Kefeli Et Al. }, title={Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience}, journal={ONCOLOGY LETTERS}, year=2013, pages={605-611} }